Back to search
FDAFDA · Food and drugs·Recall number D-0258-2022

Diclofenac Sodium Topical Solution USP, 1.5 w/w, 5 fl oz (150 mL) plastic bottles, Rx only, Teligent Pharma, Inc., Buena, New Jersey, 08310, NDC 52565-002-05

Published December 1, 2021 · Recall initiated: October 19, 2021

Summary

FDA records drug Class II recall D-0258-2022, published December 1, 2021 and initiated October 19, 2021. Recalling firm: Teligent Pharma, Inc.; Status: Terminated; Reported quantity: 2664 bottles; Lot: Lot #: 15188, Exp 2/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Container

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teligent Pharma, Inc.
Distributor
Nationwide within the United States
Lot
Lot #: 15188, Exp 2/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Diclofenac Sodium Topical Solution USP, 1.5 w/w, 5 fl oz (150 mL) plastic bottles, Rx only, Teligent Pharma, Inc., Buena, New Jersey, 08310, NDC 52565-002-05 recalled?

Yes. FDA published recall D-0258-2022 on December 1, 2021. Reported hazard: Defective Container

What should I do if I have this product?

Voluntary: Firm initiated · Letter